Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin S Channer

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Vascular Health and Risk Management|April 2, 2009
Characterization of the vasodilatory action of testosterone in the human pulmonary circulationAlyson M Smith, Robert T Bennett, T Hugh Jones, et al.
Journal of Cardiovascular Pharmacology|May 22, 2002
Pulmonary vasodilatory action of testosterone: evidence of a calcium antagonistic actionRichard D Jones, Kate M English, Peter J Pugh, et al.
European Heart Journal|August 12, 2005
Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trialChris J Malkin, Peter J Pugh, John N West, et al.
Endocrine Research|January 26, 2006
Physiologic testosterone therapy has no effect on serum levels of tumour necrosis factor-alpha in men with chronic heart failurePeter J Pugh, Richard D Jones, Chris J Malkin, et al.
Life Sciences|June 24, 2014
Testosterone suppresses the expression of regulatory enzymes of fatty acid synthesis and protects against hepatic steatosis in cholesterol-fed androgen deficient miceDaniel M Kelly, Joanne E Nettleship, Samia Akhtar, et al.
Diabetes Care|March 10, 2011
Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study)T Hugh Jones, Stefan Arver, Hermann M Behre, et al.
European Heart Journal|January 15, 2004
A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillationKevin S Channer, Andrew Birchall, Richard P Steeds, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Vascular Health and Risk Management|April 2, 2009
Characterization of the vasodilatory action of testosterone in the human pulmonary circulationAlyson M Smith, Robert T Bennett, T Hugh Jones, et al.
Journal of Cardiovascular Pharmacology|May 22, 2002
Pulmonary vasodilatory action of testosterone: evidence of a calcium antagonistic actionRichard D Jones, Kate M English, Peter J Pugh, et al.
European Heart Journal|August 12, 2005
Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trialChris J Malkin, Peter J Pugh, John N West, et al.
Endocrine Research|January 26, 2006
Physiologic testosterone therapy has no effect on serum levels of tumour necrosis factor-alpha in men with chronic heart failurePeter J Pugh, Richard D Jones, Chris J Malkin, et al.
Life Sciences|June 24, 2014
Testosterone suppresses the expression of regulatory enzymes of fatty acid synthesis and protects against hepatic steatosis in cholesterol-fed androgen deficient miceDaniel M Kelly, Joanne E Nettleship, Samia Akhtar, et al.
Diabetes Care|March 10, 2011
Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study)T Hugh Jones, Stefan Arver, Hermann M Behre, et al.
European Heart Journal|January 15, 2004
A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillationKevin S Channer, Andrew Birchall, Richard P Steeds, et al.
Pageof 6